Bankrupt FTX Seeks to Recover $71M from its Philanthropic arm

Published 20/07/2023, 12:00
Bankrupt FTX Seeks to Recover $71M from its Philanthropic arm

  • FTX lawyers seek to recover $71 million from the company’s Philanthropic and Life Science arm.
  • The court filings claim that the donations were made with ulterior motives rather than to help those in financial need.
  • This latest attempt adds to a string of others in which the company tries to recover misused funds.

Bankrupt crypto exchange FTX and its sister company Alameda Research want to recover over $71 million from its philanthropic arm and other life science entities, court documents reveal. This latest attempt follows similar actions by FTX as the now-defunct company tries to recover misappropriated funds. So far, as of June 2023, the company has recovered over $7 billion.

Per the court documents, the donations made to the company’s philanthropic arm were for “the personal aggrandizement” of Sam Bankman-Fried. According to the firm’s lawyers, the donations were made under the guise of altruism, an ideology rooted in the redistribution of wealth to the most vulnerable. Instead, the filings claim the donations were made to improve the former CEO’s goodwill and political influence.

Lumen Bioscience Inc. and Platform Life Sciences Inc. are som…

The post Bankrupt FTX Seeks to Recover $71M from its Philanthropic arm appeared first on Coin Edition.

The post Bankrupt FTX Seeks to Recover $71M from its Philanthropic arm appeared first on Coin Edition.

Read more on Coin Edition

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.